Co-occurring Challenges: Leveraging ADAP and ACA to Address Hepatitis C and Substance Use Disorders Daniel Raymond Policy Director Harm Reduction Coalition [email protected] Challenges. Hepatitis C co-infection is a leading cause of mortality in people living with HIV/AIDS
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Co-occurring Challenges: Leveraging ADAP and ACA to Address Hepatitis C and Substance Use DisordersDaniel RaymondPolicy DirectorHarm Reduction [email protected]
Genotype 1: Sovaldi/PEG/RBV, Olysio/PEG/RBV, Sovaldi/Olysio +/- RBV, Sovaldi/RBV
Genotype 2/3: Sovaldi/RBV
2013 ASAM report on MAT coverage
How to guarantee access & affordability for HCV treatment & MAT for opioid use disorders?
NASTAD ADAP Monitoring Project
AASLD/IDSA Hepatitis C Treatment Guidance
ASAM Advancing Access to Addiction Medications